Neurological Paraneoplastic Syndromes

References

• Posner J B. Neurological complications of systemic cancer. Disease-a-Month 1978; 25: 3–60
   Web of Science ®Google Scholar
• Henson R A, Urich H. Cancer and the Nervous System. The Neurological Manifestations of Systemic Malignant Disease. Blackwell Scientific Publications, London 1982
   Google Scholar
• Brierly J B, Corsellis J, Nevin R. Subacute encephalitis of later adult life Mainly affecting the limbic areas. Brain 1960; 83: 357–369
   Web of Science ®Google Scholar
• Case Records of the Massachusetts General Hospital (Case 30–1985). N Engl J Med 1985; 313: 249–257
   PubMedGoogle Scholar
• Corsellis J, Goldberg G, Norton A R. “Limbic encephalitis” and its association with carcinoma. Brain 1968; 91: 481–496
   PubMed Web of Science ®Google Scholar
• Glaser G H, Pincus J H. Limbic encephalitis. J Nervous Mental Dis 1967; 149: 59–67
   Web of Science ®Google Scholar
• Henson R A, Hoffman H L, Urich H. Encephalomyelitis with carcinoma. Brain 1965; 88: 449–464
   PubMed Web of Science ®Google Scholar
• Verhaart W J. Grey matter degeneration of the CNS in carcinosis. Acta Neuropathol 1961; 1: 107–112
   Google Scholar
• Yahr M, Duvoisin R C, Cowen D. Encephalopathy associated with carcinoma. Trans Am Neurol Assoc 1965; 90: 80–86
   PubMedGoogle Scholar
• Daniel S E, Love S, Scarvilli F, Harding A E. Encephalomyeloneuropathy in the absence of a detectable neoplasm Clinical and postmortem findings in three cases. Acta Neuropathol 1985; 66: 311–317
   PubMed Web of Science ®Google Scholar
• Langston J W, Dorfman L, Forno L. “Encephalomyeloneuritis” in the absence of cancer. Neurology 1975; 25: 633–637
   PubMed Web of Science ®Google Scholar
• Brennan L V, Craddock P R. Limbic encephalopathy as a non-metastatic complication of oat cell lung cancer. Its reversal after treatment of the primary lung lesion. Am J Med 1983; 75: 518–520
   Google Scholar
• Markham M, Abeloff M D. Small-cell lung cancer and limbic encephalitis. Ann Intern Med 1982; 96: 785
   PubMed Web of Science ®Google Scholar
• McGill T. Carcinomatous encephalomyelitis with auditory and vestibular manifestations. Ann Otolaryngol 1976; 85: 120–126
   Google Scholar
• Kaplan A M, Itabashi H H. Encephalitis associated with carcinoma Central hypoventilation syndrome with cytoplasmic inclusion bodies. J Neurol Neurosurg Psychiatr 1974; 37: 1166–1176
   PubMed Web of Science ®Google Scholar
• Pilay N, Gilbert J J, Ebers G C, Brown J D. Internuclearophthalmoplegia and “optic neuritis”: Paraneoplastic effects of bronchial carcinoma. Neurology 1984; 34: 788–791
   PubMed Web of Science ®Google Scholar
• Reddy R V, Vakili S T. Midbrain encephalitis as a remote effect of a malignant neoplasm. Arch Neurol 1981; 38: 781–782
   PubMed Web of Science ®Google Scholar
• Dorfman L J, Forno L S. Paraneoplastic encephalomyelitis. Acta Neurol Scand 1972; 48: 556–574
   PubMed Web of Science ®Google Scholar
• Torvik Slettebo A. M. Encephalomyelitis with polyneuropathy. Acta Neurol Scand 1980; 61: 287–297
   PubMed Web of Science ®Google Scholar
• Vick N, Schulman S, Dau P. Carcinomatous cerebellar degeneration, encephalomyelitis and sensory neuropathy (radiculitis) Report of a case incorporating both purely degenerative and intense inflammatory changes, with special prominence of the latter in the putamen. Neurology 1969; 19: 425–441
   PubMedGoogle Scholar
• Halperin J J, Richardson E P, Ellis J, et al. Paraneoplastic encephalomyelitis and neuropathy Report of a case. Arch Neurol 1981; 38: 773–775
   PubMed Web of Science ®Google Scholar
• Brain L, Wilkinson M. Subacute cerebellar degneration associated with neoplasms. Brain 1965; 88: 465–478
   PubMed Web of Science ®Google Scholar
• Olebaum M H, Statham R. Carcinoma of the bronchus presenting as a cerebellar neuropathy. Postgrad Med J 1961; 37: 546–549
   PubMed Web of Science ®Google Scholar
• Sarbach B. Carcinomatous cerebellar degeneration with cortical atrophy and inflammatory reaction involving the dentate nucleus: Case report. Acta Neurol Belg 1977; 77: 363–372
   PubMed Web of Science ®Google Scholar
• Satoyoshi E, Kowa H, Fukunaga T. Subacute cerebellar degeneration and Eaton-Lambert syndrome with bronchial carcinoma Case report. Neurology 1973; 23: 764–768
   PubMed Web of Science ®Google Scholar
• McDonald W I. Cortical cerebellar degeneration with ovarian carcinoma. Neurology 1961; 11: 328–334
   PubMed Web of Science ®Google Scholar
• Brazis P W, Biller J, Fine M, et al. Cerebellar degeneration with Hodgkin's disease. Computed tomographic correlation and literature review. Arch Neurol 1981; 38: 253–256
   PubMed Web of Science ®Google Scholar
• Horwich L, Buxton P H, Ryan M S. Cerebellar degeneration with Hodgkins' disease. J Neurol Neurosurg Psychiatry 1966; 29: 45–51
   PubMed Web of Science ®Google Scholar
• Rewcastle N B. Subacute cerebellar degeneration with Hodgkins' disease. Arch Neurol 1963; 9: 407–413
   PubMed Web of Science ®Google Scholar
• Trottier J L, Hendin B A, Osterland K. Cerebellar degeneration with Hodgkin's disease. Arch Neurol 1976; 33: 660–661
   PubMed Web of Science ®Google Scholar
• Kearsley J H, Johnson P, Halmagy M. Paraneoplastic cerebellar disease. Remission with excision of the primary tumor. Arch Neurol 1985; 42: 1208–1210
   Google Scholar
• Paone J F, Jeyasingham K. Remission of cerebellar dysfunction after pneumonectomy for bronchogenic carcinoma. N Engl J Med 1980; 302: 156
   PubMed Web of Science ®Google Scholar
• Cocconi G, Ceci G, Juvarra G, et al. Successful treatment of subacute cerebellar degeneration in ovarian carcinoma with plasmapheresis. Cancer 1985; 56: 2318–2320
   PubMed Web of Science ®Google Scholar
• Jaeckle K, Graus F, Houghton A, et al. Autoimmune response of patients with paraneoplastic degeneration to a Purkinje cell cytoplasmic protein antigen. Ann Neurol 1985; 18: 592–600
   PubMed Web of Science ®Google Scholar
• Greenlee J E, Brashear H R. Antibodies to cerebellar Purkinje cells in patients with paraneoplastic cerebellar degeneration and ovarian carcinoma. Ann Neurol 1983; 14: 609–613
   PubMed Web of Science ®Google Scholar
• Cunningham J, Graus F, Anderson N, Posner J B. Partial characterization of the Purkinje cell antigens in paraneoplastic cerebellar degeneration. Neurology 1986; 36: 1163–1168
   PubMed Web of Science ®Google Scholar
• Kinsboume M. Myoclonic encephalopathy of infants. J Neurol Neurosurg Psychiatry 1962; 25: 271
   PubMed Web of Science ®Google Scholar
• Brandt S, Carlsen N, Glenting P, Helweg-Larsen J. Encephalopathia myoclonica infantalis (Kinsboume) and neuroblastoma in children A report of 3 cases. Dev Med Child Neurol 1974; 16: 286–294
   PubMed Web of Science ®Google Scholar
• Bray P F, Ziter F A, Lahey M E, Myers G G. The coincidence of neuroblastoma and acute cerebellar encephalopathy. Pediatrics 1969; 75: 983–990
   Web of Science ®Google Scholar
• Martin E S, Griffith J F. Myoclonic encephalopathy and neuroblastoma Report of a case with apparent recovery. Am J Dis Child 1971; 122: 257–258
   PubMedGoogle Scholar
• Moe P G, Nellhaus G. Infantile polymyoclonia-opsocionus syndrome and neural crest tumors. Neurology 1970; 20: 756–764
   PubMed Web of Science ®Google Scholar
• Senelick R C, Bray P, Lahey M, et al. Neuroblastoma and myoclonic encephalopathy: 2 cases and a review of the literature. J Pediatr Surg 1973; 8: 623–632
   PubMed Web of Science ®Google Scholar
• Jones A, Groover R, Smithson W. Acute cerebellar encephalopathy: its natural history and relationship to neuroblastoma. Am Soc Clin Oncol Proc 1984; 22: 86
   Google Scholar
• Altman A J, Baehner R L. Favorable prognosis for survival in children with coincident opsomyodonus and neuroblastoma. Cancer 1976; 37: 846–852
   PubMed Web of Science ®Google Scholar
• Bellur S. Opsoclonus: its clinical value. Neurology 1975; 25: 502–507
   PubMed Web of Science ®Google Scholar
• Ellenberger C, Campa J F, Netsky M G. Opsoclonus and parenchymatous degeneration of the cerebellum. The cerebellar origin of an abnormal ocular movement. Neurology 1968; 18: 1041–1046
   Google Scholar
• Ross A T, Zeman W. Opsoclonus, occult carcinoma and chemical pathology in dentate nuclei. Arch Neurol 1967; 17: 546–551
   PubMed Web of Science ®Google Scholar
• Sawyer R A, Selhorst J B, Zimmerman L E, Hoyt W F. Blindness caused by photoreceptor degeneration as a remote effect of cancer. Am J Ophthalmol 1976; 81: 606–613
   PubMed Web of Science ®Google Scholar
• Keltner J L, Roth A M, Chang R S. Photoreceptor degeneration Possible automimmune disorder. Arch Ophthalmol 1983; 101: 564–569
   PubMed Web of Science ®Google Scholar
• Kornguth S E, Llein R, Appen R, Choate J. Occurrence of antiretinal ganglion cell antibodies in patients with small cell carcinoma of the lung. Cancer 1982; 50: 1289–1293
   PubMed Web of Science ®Google Scholar
• Klingele T G, Burde R M, Rappazzo J A, et al. Paraneoplastic retinopathy. J Clin Neuro-ophthalmol 1984; 4: 239–245
   PubMedGoogle Scholar
• Buchanan T AS, Gardiner T A, Archer D B. An ultrastructural study of retinal photoreceptor degeneration associated with bronchial carcinoma. Am J Ophthalmol 1984; 97: 277–287
   PubMed Web of Science ®Google Scholar
• Kornguth S E, Kalinke T, Grunwald G B, et al. Anti-neurofilament antibodies in the sera of patients with small cell carcinoma of the lung and with visual paraneoplastic syndrome. Cancer Res 1986; 46: 2588–2595
   PubMed Web of Science ®Google Scholar
• Grunwald G, Klein R, Simmonds M, Kornguth S. Autoimmune basis for visual paraneoplastic syndrome in patients with small-cell lung carcinoma. Lancet 1985; i: 658–661
   Google Scholar
• Mancall E L, Resales R K. Necrotizing myelopathy associated with visceral carcinoma. Brain 1984; 87: 639–656
   Google Scholar
• Case Records of the Massachusetts General Hospital (Case 26–1976). N Engl J Med 1976; 294: 1447–1454
   PubMedGoogle Scholar
• Handforth A, Nag S, Sharp D, et al. Paraneoplastic subacute necrotic myelopathy. Can J Neurol Set 1983; 10: 204–207
   PubMed Web of Science ®Google Scholar
• Ojeda V J. Necrotizing myelopathy associated with malignancy A clinicopathologic study of two cases and literature review. Cancer 1984; 53: 1115–1123
   PubMed Web of Science ®Google Scholar
• Case Records of the Massachusetts General Hospital (Case 51–1985). N Engl J Med 1985; 313: 1646–1656
   PubMedGoogle Scholar
• Edelson R N, Deck M DF, Posner J B. Intramedullary spinal cord metastases Clinical and radiographic findings in nine cases. Neurology (Minneapolis) 1972; 22: 1222–1231
   PubMed Web of Science ®Google Scholar
• Denny-Brown D E. Primary sensory neuropathy with muscular changes associated with cancer. J Neurol Neurosurg Psychiatry 1948; 11: 73–87
   PubMed Web of Science ®Google Scholar
• Horwich M S, Cho L, Porro R S, et al. Subacute sensory neuropathy A remote effect of carcinoma. Ann Neurol 1977; 2: 7–19
   PubMed Web of Science ®Google Scholar
• Ongerboer Devisser B W, Feltkamp-Vroom T M, Feltkamp C A. Dural nerve immune deposits in polyneuropathy as a remote effect of malignancy. Ann Neurol 1983; 14: 261–266
   PubMed Web of Science ®Google Scholar
• Graus F, Cordon-Cardo C, Posner J B. Neuronal antinuclear antibody in sensory neuropathy from lung cancer. Neurology 1985; 35: 538–543
   PubMed Web of Science ®Google Scholar
• Graus F, Elkon K B, Cordon-Cardo C, Posner J B. Sensory neuropathy and small cell lung cancer. Antineuronal antibody that also reacts with the tumor. Am J Med 1986; 80: 45–52
   Google Scholar
• Barron K D, Rodichok L D. Cancer and disorders of motor neurons. Advances in Neurology, Vol 36. Human Motor Neuron Diseases, L P Rowland. Raven Press, New York 1982; 267–272
   Google Scholar
• Rowland L P, Schneck S A. Neuromuscular disorders associated with malignant neoplastic disease. J Chronic Dis 1963; 16: 777–795
   PubMedGoogle Scholar
• Walton J N, Tomlinson B E, Pearce G W. Subacute “poliomyelitis” and Hodgkin's disease. J Neurol Set 1968; 6: 435–445
   PubMed Web of Science ®Google Scholar
• Schold S C, Cho E S, Somasundaram M, et al. Subacute motor neuropathy: A remote effect of lymphoma. Ann Neurol 1979; 5: 271–287
   PubMed Web of Science ®Google Scholar
• McLeod J G, Pollard J D. Neuropathies in systemic diseases. Hidden and overt. Peripheral Nerve Disorders, A K As-bury, R W Gillian. Butterworth International Medical Reviews, Boston 1984
   Google Scholar
• Croft P B, Wilkinson M. Carcinomatous neuromyopathy. Its incidence in patients with carcinoma of the lung and carcinoma of the breast. Lancet 1963; i: 184–188
   Google Scholar
• Walsh J C. Neuropathy associated with lymphoma. J Neurol Neurosurg Psychiatry 1971; 34: 42
   PubMed Web of Science ®Google Scholar
• Kelly J J, Kyle R A, Miles J M, et al. The spectrum of peripheral neuropathy in myeloma. Neurology 1981; 31: 24–31
   PubMed Web of Science ®Google Scholar
• Teravainen H, Larson A. Some features of the neuromuscular complications of pulmonary carcinoma. Ann Neurol 1977; 2: 495–502
   PubMed Web of Science ®Google Scholar
• Hawley R J, Cohen M H, Saini N, et al. The carcinomatous neuromyopathy of oat cell lung cancer. Ann Neurol 1980; 7: 65–72
   PubMed Web of Science ®Google Scholar
• Schaumburg H H, Spencer P S, Thomas P K. Disorders of Peripheral Nerves. F. A. Davis Co., Philadelphia 1983
   Google Scholar
• Lisak R P, Mitchell M, Zweiman B, et al. Guillain-Barre syndrome and Hodgkin's disease: 3 cases with immunological studies. Ann Neurol 1977; 1: 72–78
   PubMed Web of Science ®Google Scholar
• Kelly J J, Kyle R A, Miles J M, et al. Osteosclerotic myeloma and peripheral neuropathy. Neurology 1983; 33: 202–210
   PubMed Web of Science ®Google Scholar
• Croft P B, Urich H, Wilkinson M. Peripheral neuropathy of sensorimotor type associated with a malignant disease. Brain 1967; 90: 31–66
   PubMed Web of Science ®Google Scholar
• Eaton L M, Lambert E H. Electromyography and electric stimulation of nerves in diseases of motor unit: Observations on the myasthenic syndrome associated with malignant tumours. J Am Med Assoc 1957; 163: 117–1124
   Google Scholar
• Drachman D B, Adams R N, Josifek L F, et al. Functional activities of autoantibodies to acetylcholine receptors and the clinical severity of myasthenia gravis. N Engl J Med 1982; 307: 769–775
   PubMed Web of Science ®Google Scholar
• Hermann C, Lindstrom J M, Keesey J C, et al. Myasthenia gravis current concepts. West J Med 1985; 142: 797–809
   PubMedGoogle Scholar
• Heinrikkson K G, Nilsson O, Rosen I, et al. Clinical neurophysiological, and morphological findings in Eaton-Lambert syndrome. Acta Neurol Scand 1977; 56: 117–140
   PubMed Web of Science ®Google Scholar
• Swift T R. Disorders of neuromuscular transmission other than myasthenia gravis. Muscle and Nerve 1981; 4: 334–353
   PubMed Web of Science ®Google Scholar
• Fukunoja H, Engel A G, Osame M, et al. Paucity and disorganization of presynaptic membrane active zones in the Lambert-Eaton syndrome. Muscle and Nerve 1982; 5: 686–697
   Web of Science ®Google Scholar
• Dau P C, Denys E H. Plasmapheresis and immunosuppressive drug therapy in the Eaton-Lambert syndrome. Ann Neurol 1982; 11: 570–575
   PubMed Web of Science ®Google Scholar
• Namba T, Brunner N G, Grob D. Myasthenia gravis in patients with thymoma with particular reference to onset after thymectomy. Medicine 1978; 57: 411–433
   PubMed Web of Science ®Google Scholar
• Argov Z, Mastiglia F L. Disorders of neuromuscular transmission caused by drugs. N Engl J Med 1979; 301: 409–413
   PubMed Web of Science ®Google Scholar
• Bohan A, Peter J B, Bowman R L, et al. A computer-assisted analysis of 153 patients with polymyositis and dermatomyositis. Medicine 1977; 56: 255–286
   PubMed Web of Science ®Google Scholar
• Layzer R B. Neuromuscular Manifestation of Systemic Disease. F.A. Davis, Philadelphia 1985; 265–267
   Google Scholar
• DeVere R, Bradley W G. Polymyositis: Its presentation morbidity and mortality. Brain 1975; 98: 637–666
   PubMed Web of Science ®Google Scholar
• Callen J P, Hyala J F, Bole G G, Jr, et al. The relationship of dermatomyositis and polymyositis to internal malignancy. Arch Dermatol 1980; 116: 295–298
   PubMed Web of Science ®Google Scholar
• Lakhanpal S, Bunch T W, Ilstrup D M, Melton L J. Polymyositisdermatomyositis and malignant lesions: Does an association exist. Mayo Clin Proc 1986; 61: 645–653
   PubMed Web of Science ®Google Scholar
• Barron S A, Heffner R R. Weakness and malignancy: Evidence for a remote effect of tumor on distal axons. Ann Neurol 1978; 4: 268–274
   PubMed Web of Science ®Google Scholar
• Sack G H, Levin J, Bell W. Trousseau's syndrome and other manifestations of chronic disseminated coagulopathy in patients with neoplasms Clinical, pathophysiologic and therapeutic results. Medicine 1977; 56: 1–37
   PubMed Web of Science ®Google Scholar
• Rickles F R, Edwards R L, Barb C, Cronland M. Abnormalities of blood coagulation in patients with cancer Fibrinopeptide A generation and tumor growth. Cancer 1983; 51: 301–307
   PubMed Web of Science ®Google Scholar
• Min K, Gyorkey F, Sato C. Mucin-producing adenocarcinomas and non-bacterial thrombotic endocarditis, Pathogenetic role of tumor muchin. Cancer 1980; 45: 2374–2382
   PubMed Web of Science ®Google Scholar
• Rosen P, Armstrong D. Non-bacterial thrombotic endocarditis in patients with malignant neoplastic diseases. Am J Med 1973; 54: 23–29
   PubMed Web of Science ®Google Scholar
• Bryan C S. Nonbacterial thrombotic endocarditis with malignant tumors. Am J Med 1969; 46: 787–793
   PubMed Web of Science ®Google Scholar
• Biller J, Challa V R, Toole J F, Howard V J. Nonbacterial thrombotic endocarditis A neurologic perspective of clinico-pathologic correlations of 99 patients. Arch Neurol 1982; 39: 95–98
   PubMed Web of Science ®Google Scholar
• Graus F, Rogers L R, Posner J B. Cerebrovascular complications in patients with cancer. Medicine 1985; 64: 16–35
   PubMed Web of Science ®Google Scholar
• Kooiker J C, MacLean J M, Sumi S M. Cerebral embolism, marantic endocarditis and cancer. Arch Neurol 1976; 33: 260–264
   PubMed Web of Science ®Google Scholar
• Barron K D, Siqueira E, Hirano A. Cerebral embolism caused by non-bacterial thrombotic endocarditis. Neurology 1960; 10: 391–397
   PubMed Web of Science ®Google Scholar
• Kim H, Suzuki M, Lie J T, Titus J L. Nonbacterial thrombotic endocarditis (NBTE) and disseminated intravascular coagulation (DIC) Autopsy study of 36 patients. Arch Pathol Lab Med 1977; 101: 65–68
   PubMed Web of Science ®Google Scholar
• Collins R C, Mondhiry H, Chernik N L, Posner J B. Neurologic manifestations of intravascular coagulation in patients with cancer A clinico-pathologic analysis of 12 cases. Neurology 1975; 25: 795–806
   PubMed Web of Science ®Google Scholar
• Schwartzman R J, Hill J B. Neurological complications of disseminated intravascular coagulation. Neurology 1982; 32: 791–797
   PubMed Web of Science ®Google Scholar
• Godal H C, Abildgaard A. The symptomatic effect of anticoagulant therapy in defibrination syndrome associated with demonstrable fibrin in plasma A case report. Acta Med Scand 1963; 174: 311–314
   PubMed Web of Science ®Google Scholar
• Hickey W F, Garnick M B, Henderson I C, Dawson D M. Primary cerebral venous thrombosis in patients with cancer—a rarely diagnosed paraneoplastic syndrome Report of 3 cases and review of the literature. Am J Med 1982; 73: 740–751
   PubMed Web of Science ®Google Scholar
• Sigsbee B, Deck M, Posner J B. Nonmetastatic superior sagittal sinus thrombosis complicating systemic. Cancer 1979; 29: 139–146
   Google Scholar